VRtuose project website was launched by IARC on 22 July 2025, detailing the use of virtual reality combined with music to support patients undergoing chemotherapy, particularly for breast cancer. Developed with Centre Léon Bérard (Lyon) and funded through the Ruban Rose 2023 Quality-of‑Life prize, the initiative evaluates feasibility, acceptability, and tolerability in clinical settings.
It aims to reduce anxiety, improve treatment adherence, and enhance patient well‑being, with plans to scale across European centres. Conducting this study will provide information about whether the use of VR distraction tools fits the needs of patients with breast cancer who are undergoing chemotherapy and whether it is compatible with clinical practice.
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959